Payment overview · 2025
General Payments
$19.69
1 reported records · 1 companies
Healthcare provider profile · identity verified
Timothy Victor Smith
Allopathic & Osteopathic Physicians|Family Medicine · HOLLAND, MI · NPI 1295828820
Verified facts
What the public records show
CMS Open Payments records show Timothy Victor Smith received $19.69 in general payments during 2025 across 1 reported records.
PFIZER INC. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 4 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Abrysvo.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ABRYSVO as an associated drug or biological on 55380 records involving 31565 distinct recipient NPIs. Public Medicare Part D data also shows 63 claims for Abrysvo by this doctor in 2024.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ELIQUIS as an associated drug or biological on 87112 records involving 36032 distinct recipient NPIs. Public Medicare Part D data also shows 108 claims for Eliquis by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| PFIZER INC. | Unresolved — no canonical attribution shown | $19.69 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $19.69 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| ABRYSVO Normalized: abrysvo |
Biological | PFIZER INC. | $19.69 | 1 | 2025 |
Source payment records
|
|||||
| COMIRNATY Normalized: comirnaty |
Biological | PFIZER INC. | $19.69 | 1 | 2025 |
Source payment records
|
|||||
| PREVNAR 20 Normalized: prevnar 20 |
Biological | PFIZER INC. | $19.69 | 1 | 2025 |
Source payment records
|
|||||
| TRUMENBA Normalized: trumenba |
Biological | PFIZER INC. | $19.69 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| ABRYSVO abrysvo |
2025 | Abrysvo | 2024 | 63 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | ABRYSVO open payments reported associated product |
CMS Open Payments — General Payments 55380 supporting records · 31565 recipient NPIs · example record 1228794147 |
Abrysvo · 2024 Exact normalized brand match · 1 Part D row |
63 | 63 |
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | ELIQUIS open payments reported associated product |
CMS Open Payments — General Payments 87112 supporting records · 36032 recipient NPIs · example record 1228794063 |
Eliquis · 2024 Exact normalized brand match · 1 Part D row |
108 | 18 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 476 | 136 |
| Amlodipine Besylate | Amlodipine Besylate | 457 | 119 |
| Lisinopril | Lisinopril | 419 | 109 |
| Levothyroxine Sodium | Levothyroxine Sodium | 347 | 92 |
| Losartan Potassium | Losartan Potassium | 328 | 95 |
| Hydrochlorothiazide | Hydrochlorothiazide | 304 | 84 |
| Omeprazole | Omeprazole | 277 | 74 |
| Metformin Hcl | Metformin Hcl | 251 | 62 |
| Alprazolam | Alprazolam | 248 | 69 |
| Metoprolol Succinate | Metoprolol Succinate | 228 | 58 |
| Potassium Chloride | Potassium Chloride | 211 | 50 |
| Tamsulosin Hcl | Tamsulosin Hcl | 204 | 56 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 171 | 58 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 155 | 49 |
| Trazodone Hcl | Trazodone Hcl | 151 | 33 |
| Sertraline Hcl | Sertraline Hcl | 132 | 37 |
| Gabapentin | Gabapentin | 127 | 39 |
| Glipizide Er | Glipizide | 125 | 32 |
| Furosemide | Furosemide | 124 | 29 |
| Fluoxetine Hcl | Fluoxetine Hcl | 122 | 27 |
| Duloxetine Hcl | Duloxetine Hcl | 117 | 30 |
| Eliquis | Apixaban | 108 | 18 |
| Pioglitazone Hcl | Pioglitazone Hcl | 104 | 29 |
| Estradiol | Estradiol | 103 | 33 |
| Finasteride | Finasteride | 101 | 31 |
| Bupropion Hcl Sr | Bupropion Hcl | 98 | 24 |
| Clonazepam | Clonazepam | 97 | 22 |
| Zolpidem Tartrate | Zolpidem Tartrate | 95 | 20 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 92 | 30 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 91 | 22 |
| Alendronate Sodium | Alendronate Sodium | 89 | 27 |
| Metoprolol Tartrate | Metoprolol Tartrate | 88 | 25 |
| Pravastatin Sodium | Pravastatin Sodium | 88 | 28 |
| Mounjaro | Tirzepatide | 83 | 20 |
| Simvastatin | Simvastatin | 82 | 21 |
| Buspirone Hcl | Buspirone Hcl | 77 | 13 |
| Montelukast Sodium | Montelukast Sodium | 77 | 19 |
| Allopurinol | Allopurinol | 75 | 21 |
| Prednisone | Prednisone | 74 | 39 |
| Tramadol Hcl | Tramadol Hcl | 74 | 23 |
| Pantoprazole Sodium | Pantoprazole Sodium | 71 | 18 |
| Famotidine | Famotidine | 69 | 24 |
| Meloxicam | Meloxicam | 68 | 20 |
| Abrysvo | Rsv Vacc, Pref A And Pref B/Pf | 63 | 63 |
| Donepezil Hcl | Donepezil Hcl | 59 | 13 |
| Warfarin Sodium | Warfarin Sodium | 59 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 55 | 14 |
| Fluconazole | Fluconazole | 55 | 24 |
| Fluticasone Propionate | Fluticasone Propionate | 55 | 18 |
| Spironolactone | Spironolactone | 54 | 15 |
| Temazepam | Temazepam | 54 | 12 |
| Atenolol | Atenolol | 52 | 15 |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 52 | 49 |
| Adacel Tdap | Diph,pertuss(Acell),tet Vac/Pf | 51 | 51 |
| Escitalopram Oxalate | Escitalopram Oxalate | 50 | 15 |
| Metformin Hcl Er | Metformin Hcl | 49 | 16 |
| Ibuprofen | Ibuprofen | 48 | 15 |
| Irbesartan | Irbesartan | 47 | 13 |
| Lorazepam | Lorazepam | 47 | 15 |
| Lovastatin | Lovastatin | 46 | 12 |
| Clopidogrel | Clopidogrel Bisulfate | 44 | 14 |
| Doxycycline Hyclate | Doxycycline Hyclate | 41 | 17 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 39 | suppressed |
| Bupropion Xl | Bupropion Hcl | 38 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 36 | 11 |
| Pregabalin | Pregabalin | 36 | 12 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 36 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 36 | 25 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 35 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 35 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 35 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 35 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 34 | suppressed |
| Cyanocobalamin Injection | Cyanocobalamin (Vitamin B-12) | 34 | 11 |
| Klor-Con M20 | Potassium Chloride | 34 | suppressed |
| Topiramate | Topiramate | 34 | suppressed |
| Minoxidil | Minoxidil | 33 | 13 |
| Diclofenac Sodium | Diclofenac Sodium | 32 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 31 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 31 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 31 | suppressed |
| Carvedilol | Carvedilol | 30 | 11 |
| Desmopressin Acetate | Desmopressin Acetate | 30 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 30 | 17 |
| Hydrocortisone | Hydrocortisone | 29 | suppressed |
| Jantoven | Warfarin Sodium | 29 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 29 | 13 |
| Propranolol Hcl | Propranolol Hcl | 29 | suppressed |
| Trulicity | Dulaglutide | 29 | suppressed |
| Jardiance | Empagliflozin | 28 | suppressed |
| Valsartan | Valsartan | 28 | 12 |
| Ezetimibe | Ezetimibe | 27 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 27 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 27 | suppressed |
| Methylprednisolone | Methylprednisolone | 26 | 24 |
| Propranolol Hcl Er | Propranolol Hcl | 26 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 26 | 12 |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 25 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 25 | suppressed |
| Probenecid | Probenecid | 25 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 25 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 25 | 16 |
| Clobetasol Propionate | Clobetasol Propionate | 23 | 11 |
| Diltiazem 24hr Er | Diltiazem Hcl | 23 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 23 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 23 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 22 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 22 | suppressed |
| Torsemide | Torsemide | 22 | suppressed |
| Nystatin | Nystatin | 21 | suppressed |
| Dutasteride | Dutasteride | 20 | suppressed |
| Glimepiride | Glimepiride | 19 | suppressed |
| Verapamil Er | Verapamil Hcl | 19 | suppressed |
| Xarelto | Rivaroxaban | 19 | suppressed |
| Diazepam | Diazepam | 18 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 18 | suppressed |
| Azithromycin | Azithromycin | 17 | 16 |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 17 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 17 | suppressed |
| Digoxin | Digoxin | 17 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 17 | suppressed |
| Estradiol (Twice Weekly) | Estradiol | 17 | suppressed |
| Levetiracetam | Levetiracetam | 17 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 17 | suppressed |
| Methadone Hcl | Methadone Hcl | 17 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 16 | 14 |
| Glipizide | Glipizide | 16 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 16 | suppressed |
| Ozempic | Semaglutide | 16 | suppressed |
| Tramadol Hcl Er | Tramadol Hcl | 16 | suppressed |
| Cephalexin | Cephalexin | 15 | 14 |
| Cimetidine | Cimetidine | 15 | suppressed |
| Fentanyl | Fentanyl | 15 | suppressed |
| Folic Acid | Folic Acid | 15 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 15 | suppressed |
| Myrbetriq | Mirabegron | 15 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 15 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 14 | suppressed |
| Repaglinide | Repaglinide | 14 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 13 | 12 |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 13 | suppressed |
| Diclofenac Sodium-Misoprostol | Diclofenac Sodium/Misoprostol | 13 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 13 | suppressed |
| Fluvoxamine Maleate | Fluvoxamine Maleate | 13 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 13 | suppressed |
| Amoxicillin | Amoxicillin | 12 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 12 | suppressed |
| Calcitriol | Calcitriol | 12 | suppressed |
| Colesevelam Hcl | Colesevelam Hcl | 12 | suppressed |
| Diclofenac Potassium | Diclofenac Potassium | 12 | suppressed |
| Dulera | Mometasone/Formoterol | 12 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 12 | suppressed |
| Ethosuximide | Ethosuximide | 12 | suppressed |
| Humalog | Insulin Lispro | 12 | suppressed |
| Ketoconazole | Ketoconazole | 12 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 12 | suppressed |
| Synthroid | Levothyroxine Sodium | 12 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 12 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 12 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 11 | suppressed |
| Fenofibrate | Fenofibrate | 11 | suppressed |
| Linzess | Linaclotide | 11 | suppressed |
| Methylphenidate Er | Methylphenidate Hcl | 11 | suppressed |
| Minocycline Hcl | Minocycline Hcl | 11 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 11 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $19.69 · 1 records | PFIZER INC. | ABRYSVO, COMIRNATY, PREVNAR 20, TRUMENBA | 2 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Abrysvo play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with PFIZER INC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error